There are several lines of evidence which suggest that chromosome 4p may contain a major susceptibility locus for the functional psychoses. We previously reported a family (family 50) with cases of schizophrenia and schizoaffective disorder which gave maximum lod scores of 1.96 and 1.84 respectively with the markers D4S403 and a microsatellite near to DRD5 (DRD5-M). More recently Blackwood and co-workers described a family segregating bipolar and unipolar affective disorders which gives a maximum lod score of 4.1 with the marker D4S394, which lies 10 cM from D4S403. They obtained a combined maximum lod of 3.3 in their total sample of 12 bipolar families and found significant evidence of heterogeneity ( 2 = 18.8, df = 2, P = 0.00008). Here we report the results of a linkage study of chromosome 4p markers in a sample of 24 multiply affected families with schizophrenia and related disorders. We obtained an overall maximum lod of 1.12 with D4S403 under both dominant and recessive modes of transmission, with no statistical support for heterogeneity within our sample. Examination of family by family data shows that only family 50 appears to show linkage at this locus. However, a discrepancy exists since our study examined families fulfilling criteria for a linkage study of schizophrenia while Blackwood et al examined families included in a genetic linkage study of bipolar disorder. This may be explained by the clinical features displayed by members of family 50, which show that all the affected members have some affective symptoms. It is therefore possible that a broad phenotype including unipolar depression, bipolar disorder, schizoaffective disorder and schizophrenia when accompanied by significant affective symptoms can result from mutations within a gene in this region. The dopamine D5 receptor gene lies within the region identified by the linkage studies and is therefore a major candidate for the putative disease gene. In family 50 we have looked for mutations of DRD5 by sequence analysis of the coding region and single stranded conformational polymorphism (SSCP) analysis of the promoter. SSCP analysis of the coding and promoter regions have also been carried out in unrelated cases of DSM-IIIR schizophrenia. Finally association studies of the (TC) n repeat in the promoter and schizophrenia, and DRD5-M and bipolar disorder were performed. These studies provided no further evidence supporting the possibility that mutations in DRD5 give rise to the linkage findings or are acting as susceptibility loci in schizophrenia or bipolar disorder.
Introduction
Several lines of evidence suggest that the short arm of chromosome 4 contains a major susceptibility locus for the functional psychoses. We have reported a family with cases of schizophrenia and schizoaffective dis-order (family 50) which gave maximum lod scores of 1.96 and 1.84 with the markers D4S403 and a microsatellite near to DRD5 (DRD5-M). 1 In a recent report, Blackwood et al 2 describe a single family with multiple members affected with bipolar and unipolar affective disorders which gives a maximum lod score of 4.1 with the marker D4S394, which lies 10 cM from D4S403. Furthermore they obtained a combined maximum lod of 3.3 in their total sample of 12 bipolar families and found significant evidence of heterogeneity ( 2 = 18.8, df = 2, P = 0.00008).
Earlier studies of markers from the same region examined samples of families segregating schizophrenia and related disorders. Coon et al 3 examined three markers from this region in a sample of nine such families and found no evidence for linkage in the combined sample. In a further study from the same group 4 another 23 families were typed for DRD5-M. Again combined lod scores were negative, although one family gave a lod score of 1.05 on its own under a recessive mode of transmission. More recently Kalsi et al 5 studied the DRD5-M in 11 Icelandic and 12 English pedigrees but found no evidence of linkage.
Further evidence for the existence of a susceptibility locus within this region comes from an association study of DRD5-M and schizophrenia which suggests there may be linkage disequilibrium between the marker and disease gene (P = 0.01).
6 DRD5 was cloned and mapped to 4p15.1-16.1 7, 8 and more recently the promoter region was characterised. 9 The precise location of DRD5 was first assigned by Sherrington et al 10 who isolated a microsatellite (DRD5-M) from a cosmid clone containing DRD5 and demonstrated tight linkage to the chromosome 4p reference marker RAF1P1. The published CEPH-Average map shows DRD5 lying between D4S394 and D4S403 (Genome DataBase) and this position agrees with its location on a physical YAC map of the region (Research Genetics, Huntsville, AL, USA). The linkage results to date suggest that if the positive results are coming from a true susceptibility locus, then this locus lies proximal to the marker D4S394. DRD5 lies within this region and is therefore a major contender as the causative gene and the presence of a susceptibility locus within this gene may explain the results of the association study with DRD5-M.
DRD5 has a similar genomic structure to the dopamine D1 receptor gene (DRD1), having a single small exon within the 5′ untranslated region. 11 The receptors share many functional properties since they both stimulate adenylate cyclase activity, although DRD5 binds dopamine with a 10-fold greater affinity than DRD1. 8 A role for either of these receptors in the aetiology of bipolar disorder and schizophrenia has not received nearly as much attention as the dopamine D2, D3 and D4 receptors since pharmacological studies have suggested that it is the D2-like receptors which mediate the effects of anti-psychotic drugs. 12 Furthermore the detailed mutational analysis of the DRD5 coding region by Sobell et al 11 appeared to rule out any significant role for the gene in the majority of cases of schizophrenia. They screened the coding region for mutations in 78 unrelated schizophrenic individuals by dideoxy-fingerprinting, a method that detects essentially 100% of mutations. Five sequence changes were found which altered amino acids but no relationship was found between these and schizophrenia. The promoter for human DRD5 has also been characterised and a polymorphic (TC) n repeat isolated from this region. 13 However, no association between alleles of the (TC) n repeat schizophrenia was observed in a small sample of schizophrenia cases and controls. Despite these observations, because of the role of the D5 receptor in dopamine neurotransmission and its presence within the prefrontal cortex and limbic structures such as the hippocampus, the gene remains a candidate for involvement in schizophrenia and bipolar disorder.
Here we report linkage findings of chromosome 4p markers in a sample of 24 families multiply affected with schizophrenia and related disorders. In family 50 we have looked for mutations of DRD5 by sequence analysis of the coding region and single stranded conformational polymorphism (SSCP) analysis of the promoter. SSCP analysis of the coding and promoter regions has also been carried out in unrelated cases of DSM-IIIR schizophrenia. Finally association studies of the (TC) n repeat in the promoter and schizophrenia, and DRD5-M and bipolar disorder were performed.
Materials and methods

Linkage study of multiply affected pedigrees
One hundred and ninety-one individuals in 24 families with multiple cases of schizophrenia and related disorders were examined and had blood taken. A full description of these families and selection criteria has been reported elsewhere.
14 Pedigrees were selected for their Mendelian appearance and may therefore form a sub-group of families segregating a gene or genes of major effect. Eight families came from Wales and these were interviewed using a lifetime version of the Present State Examination (PSE). 15 This information plus additional questions and the use of case notes enabled the operational criteria checklist (OPCRIT) 16 to be completed, and diagnoses to be made according to various diagnostic criteria including Research Diagnostic Criteria (RDC) and DSM-IIIR. 17 Of the remaining families, 13 came from south-east England, one from Eire and two from Japan. These were interviewed using the lifetime version of the Schedule for Affective Disorder and Schizophrenia (SADS-L) 17 enabling RDC diagnoses to be made.
As in previous studies, we used general and restricted diagnostic categories and eight sets of genetic parameters representing a range of plausible single-gene models from near dominant to fully recessive ( Table 1) . The restricted diagnostic criteria include all individ- Microsatellite markers and linkage analysis Highly polymorphic microsatellite markers ( Figure 1 ) were chosen from the Généthon catalogue 22 and from published reports of markers close to the alpha 2 C adrenergic receptor gene (A2C) 23 and the gene for the beta 1 subunit to the GABA A receptor (GABAB1). 24 Primers for these are listed in Table 2 . Lod scores and map distances were calculated using the LINKAGE program 25 and heterogeneity tested using the A test (HOMOG). 26 
Study of family 50
In family 50 ( Figure 2 ) clinical and genotype data have been collected on five affected and nine unaffected individuals. Phenotypic data from this family, which is part of our linkage study of schizophrenia, is interesting since all affected individuals have a striking affective component to their illness. Individual 01 has an RDC diagnosis of psychosis NOS due to a paucity of detailed clinical information, and has a clinical picture which is compatible with either an affective or schizophrenic disorder. Individual 03 has an RDC diagnosis of schizophrenia despite the presence of clinical features more typical of manic states. Finally, individuals 10, 11 and 12 all have an RDC diagnosis of schizoaffective disorder with clinical features of both schizophrenia and bipolar disorder.
Association studies
Schizophrenia
The (TC) n microsatellite within the DRD5 promoter region 13 was studied in a sample of 107 DSM-IIIR schizophrenic cases and 101 controls. This sample Figure 1 Map of markers used in the linkage study of multiplex families. Map distances were taken from the latest Genethon map (Ɇ) or were estimated from our own data (ɆɆ). Published distances agreed with our own data, calculated using ILINK. DRD5 maps between D4S394 and D4S403 (Genome DataBase, Research Genetics Inc).
consists of one affected member of each of a sample of affected sibling pairs collected in Wales. Controls were taken from a blood donor clinic in Cardiff and individuals carefully matched for ethnicity, age and sex. Blood donor controls were not screened to exclude psychiatric illness. 27 Bipolar disorder DRD5-M was studied in a sample of 120 cases of DSM-IIIR bipolar disorder (BP) cases and 111 blood donor controls matched for ethnicity, age and sex. DRD5-M has been previously typed in our schizophrenia association sample. 6 BP cases consisted of UK Caucasians recruited from psychiatric outpatient clinics in England and Wales. Final diagnoses were derived from OPCRIT using information from a structured interview (SADS-L) and case notes. Blood donor controls were not screened to exclude psychiatric illness.
Single stranded conformational polymorphism (SSCP) analysis
Specific amplification of DRD5 is complicated by the presence of two pseudogenes located on chromosome 2p and 1q which share 98% homology with the gene. 28 PCR primers were designed which amplified the coding region of DRD5 in two fragments. The 3′ fragment amplified without pseudogene contamination (checked by gene-specific digest with PssI). Nested PCR primers were then designed to amplify four overlapping fragments of suitable size for SSCP analysis. The 5′ fragment however, did not amplify without pseudogene contamination. This fragment was therefore digested with DdeI, a gene-specific digest, and the resulting fragments isolated from the gel. Nested PCR primers were then used to amplify three overlapping fragments using the isolated fragments as templates, which were then subjected to SSCP analysis. 29 The DRD5 promoter region 9 was amplified in seven overlapping fragments prior to SSCP analysis. PCR amplification and SSCP analysis were carried out using standard procedures. 30 Primers used in these procedures are listed in Table 2 .
Direct sequencing of DRD5 coding region in family 50
The coding region of DRD5 was sequenced in individuals 01, 02, 03 and 04 from family 50 ( Figure 2 ). The region was amplified using PCR primers designed by Sobell et al 11 which contain gene-specific sequences at their 3′ ends and do not therefore amplify pseudogene. Nested primers were used to amplify smaller fragments from these for direct sequencing. These primers had the M13(-21) universal sequence at their 5′ ends, enabling standard sequencing kits to be used. Sequencing was carried out using fluorescently labelled primers with either Taq-CS (Perkin-Elmer, Foster City, USA) or Thermosequenase (Amersham International, Amersham, UK) and analysed on an ABI373 (PerkinElmer). Sequence data were examined for heterozygotes using Sequence Navigator (Perkin-Elmer) and by eye. Primers are listed in Table 2 .
Results
Linkage analysis of multiplex families
In the linkage study of 24 multiply affected families, seven microsatellite markers were typed which span chromosome 4p (Figure 1) . The results are summarised in Table 3 (a) and (b). The highest overall lod score of 1.12 was obtained with D4S403 using the general diagnostic criteria and both dominant and recessive models of transmission. While this result falls well short of evidence for linkage when considered on its own, it is notable that a single family (family 50) contributes most to the positive lod score (Table 4a ). DRD5-M gives lower overall lod scores, but there are no recombinants with this marker in affected members of family 50 (Table 4b ). Testing these data for heterogeneity using the A-Test (HOMOG) did not provide significant evidence for admixture. Using conventional criteria for exclusion (lod Ͻ −2), virtually the entire region can be ruled out under the assumption of genetic homogeneity. However, as in previous studies with this sample, the ability to exclude a region drops away dramatically as the proportion of linked families is decreased 20,31 and this is reflected by the inability to exclude the region close to DRD5 at an ␣ value (proportion of linked families) of 0.8 or less. Marker data were also used to estimate the position of DRD5 using LINKMAP. 26 The best estimate position of DRD5 was centromeric to D4S403, although a location between D4S403 and D4S394 is also plausible (Figure 3 ).
Sequencing and SSCP analysis of DRD5
SSCP analysis of the coding region of DRD5 was performed in 12 members of family 50, plus 18 unrelated cases of DSM-IIIR schizophrenia. One of the seven SSCP reactions, with primers 1292 and 3′Seq showed a clear conformational shift. 29 Two different conformers were identified which were sequenced to reveal base pair substitutions C1481T and G1491C, both silent mutations. The G1491C substitution was seen in only one out of 107 cases of DSM-IIIR schizophrenia. The C1481T polymorphism was much more common, and was analysed in 100 DSM-IIIR schizophrenics and 103 matched controls (Table 5 ). There was no significant difference in either allele frequencies ( 2 = 0.34, df = 1, NS) or genotype frequencies ( 2 = 2.267, df = 2, NS) between cases and controls. The C1481T polymorphism had been previously described by Sobell et al, 11 but we failed to detect any of the other variants they described, including the common T978C. The coding region was sequenced in four members of family 50 (01, 02, 03 and 04), but no sequence variation was revealed. SSCP analysis of the promoter region was performed in the same four members of family 50 plus 36 unrelated individuals with DSM-IIIR schizophrenia, but no polymorphisms in addition to the previously described (TC) n repeat were revealed. The polymorphisms (TC) n , C1481T and T978C all showed common homozygote genotypes and were therefore uninformative in this family.
Association studies in schizophrenia and bipolar samples
Results of the association studies between the (TC) n repeat in the promoter and schizophrenia ( 2 = 7.00, df = 5, NS) and DRD5-M and bipolar disorder ( 2 = 10.75, df = 11, NS) are shown in Tables 6 and 7 respectively. There was no evidence of allelic association in either study.
Discussion
Chromosome 4p is of considerable interest as the possible location of a major susceptibility locus for bipolar affective disorder. 2, 32 In a study of 12 families, Blackwood and colleagues obtained maximum multipoint lod scores of 3.3 with significant evidence of locus heterogeneity with markers around D4S394. They also described a single family which on its own gives a maximum lod score of 4.1 with D4S394. Examination of haplotypes within this large pedigree showed the transmission of a single haplotype extending from D4S431 to D4S403 in all cases of bipolar disorder and 14/16 cases of recurrent unipolar depression. These data suggest strongly that there may be a major susceptibility locus for major affective disorders on chromosome 4p.
In this study we have examined a sample of 24 multiply affected families segregating predominantly schizophrenia and schizoaffective disorders. On the basis of our selection criteria 14 these families were all included in genetic studies of schizophrenia. The results of our linkage study provide weak evidence for linkage, with a maximum lod score of 1.2 with the marker D4S403 under both dominant and recessive models of transmission. There was no significant evidence of heterogeneity in our data and examination of the family by family lod scores shows that only family 50 is a clear contender for linkage to this locus, although positive lod scores were seen in three further families. It should be noted that due to recombinants in family 50 between the markers D4S394 and D4S403, the combined lod score maximises with D4S403 and not with D4S394 as in the study of Blackwood et al.
In order to assess the significance of the DRD5-M lod scores in family 50, a simulation was performed using SIMLINK. Genotypes for founding members (50-01, 50-02 and 50-04) were fixed and simulation of other genotypes performed under the general diagnostic criteria with genetic parameter model 2. The lod score of 1.84 at = 0 was achieved 14 times in 10 000 (0.0014). This figure cannot be considered to be a true P value, since no account has been taken of the other 23 families studied and an appropriate adjustment needs to be made for the low prior odds of linkage. We can state that on its own this finding does not amount to evidence for linkage, however in the context of other studies describing linkage to the same genetic markers the possibility of linkage to this family must be taken seriously.
The important findings are therefore that in each of the two studies a family was identified which may be linked to the same set of markers on chromosome 4p. However, a major discrepancy appears to exist since our study examined families fulfilling criteria for a linkage study of schizophrenia while Blackwood et al 2 examined families included in a genetic linkage study of bipolar disorder. Details of the clinical features displayed by members of family 50 are therefore worth considering and it is interesting to observe that all the affected members of family 50 have a number of clinical features which are typical of affective disorders. For example individual 50-12 described grandiose delusions and feelings of elation despite an outwardly flat and apathetic appearance. Individual 50-03 appears to have a more typical form of schizophrenia but even she presented with many affective symptoms. For example her mood was often irritable and labile and she showed sexually disinhibited behaviour. At times she was described as garrulous, talking rapidly with flight of ideas and she has had grandiose delusions. The two members of the family with diagnoses of RDC/DSM-IIIR schizoaffective disorder have more obvious manic features. Individual 50-11 at times displayed a full manic syndrome with overactivity, disinhibited behaviour, pressure of speech and flight of ideas, elated mood and grandiose delusions. The diagnosis of schizoaffective disorder was based on periods in which these affective symptoms had resolved and during which he described a wide variety of non-affective psychotic symptoms. Individual 50-10 has what appears to be a more typical form of manic depressive illness. Prior to the onset of a manic episode she reported a sustained period of severe depression fulfilling criteria for major depression. The manic phase was typical with overactivity, elated mood and her actions were based upon grandiose thoughts and delusions. The diagnosis of schizoaffective disorder in this case was more difficult to make and was based upon the judgement that continued grandiose and persecutory thoughts after the affective symptoms had resolved were delusional. However it could be argued that these thoughts fulfil the definition of overvalued ideas (not delusions), since she received a great deal of local church support for her ideas which were deeply religious and therefore culturally bound. In this case her diagnosis would be one of manic depression under DSM-IIIR criteria (but not RDC criteria). Finally, individual 50-01 could not be assessed fully due to lack of detailed clinical information but there is evidence that he may have suffered an affective illness since he is described as withdrawn, deeply depressed and suicidal and he expressed the belief that he was married to the Queen. If it turns out that family 50 is indeed a 4p-linked family then the clinical features of affected members suggest that the primary phenotypic characteristic shared by all affecteds may be the presence of affective symptoms. If this is correct then these data suggest that a gene on 4p gives rise to a broad phenotype including recurrent unipolar depression, bipolar disorder, schizoaffective disorder and schizophrenia when accompanied by significant affective symptoms.
This conclusion may appear surprising to those who are not familiar with psychiatric literature, but in fact the division between schizophrenia and bipolar disorder remains controversial. Attempts to define the boundary between the two disorders on the basis of symptom and outcome variables have failed 33, 34 and some authors have gone as far as to propose that there is a continuum of psychoses resulting from the same genetic mutations. 35, 36 Data from family studies suggest that by and large the two disorders are genetically distinct. 37 However there may be rare genetic subtypes of psychosis, such as that in family 50, that can manifest in either form.
We also examined a sample of bipolar disorder cases for association with DRD5-M. However, in 120 cases of bipolar I disorder and matched controls there was not evidence suggestive of association. The association reported by Williams et al 6 between schizophrenia and DRD5-M therefore suggests that DRD5 may be a susceptibility locus which is specific for schizophrenia. In this case it is unlikely that a link exists between the schizophrenia association and the 4p-linkage since the association sample consisted of DSM-IIIR schizophrenics, few of whom had significant affective symptoms. In fact it is not unlikely that the schizophrenia association is merely a chance finding. This later conclusion is supported by the inability to detect mutations associated with schizophrenia within the coding or promoter regions of DRD5, although it remains feasible that another gene with mutations in linkage disequilibrium with DRD5-M may be involved or that a susceptibility locus lies elsewhere in the regulatory region of the gene.
In this study we screened the DRD5 promoter region by SSCP analysis in 36 cases of DSM-IIIR schizophrenia and found no polymorphic variation apart from the (TC) n repeat polymorphism described by Beischlag et al. 13 An association study with this poly-morphism found no relationship with schizophrenia. However it is possible that SSCP analysis has failed to pick up all sequence variation within the promoter region.
In order to examine further the possible role of DRD5 mutations in family 50, we screened both the coding and promoter regions of DRD5, but failed to find any polymorphisms which explained the linkage findings. These negative findings support those of Blackwood et al 2 who examined the coding region of DRD5 in their 'linked' family by chemical cleavage. It is therefore unlikely that a mutation within the coding region of DRD5 confers susceptibility to chromosome 4p-linked families. However, it remains possible that regulatory regions are involved, since SSCP used to screen the promoter has no more than a 90% detection rate and regions further upstream have not been screened.
Summary
In conclusion we have carried out a linkage study of chromosome 4p markers in a sample of families with mainly schizophrenia and schizoaffective diagnoses. While this study does not provide significant evidence for linkage when considered alone it may be considered to support the findings of Blackwood et al. 2 Of particular interest is the identification of a family which appears to be linked to the same set of chromosome 4p markers. Study of this family suggests that a broad phenotype including unipolar depression, bipolar disorder, schizoaffective disorder and schizophrenia when accompanied by significant affective symptoms results from gene mutations within this region. The possibility that DRD5 gives rise to these findings has been explored and shown to be unlikely.
The proposed mode of transmission for the putative disease gene appears to be Mendelian, at least in some families. If this is the case then future work aimed at isolating the gene will be simplified since conventional positional cloning strategies can be adopted. A first step towards this would be to search for other families showing linkage to this locus which can further cut down the size of the candidate region which currently remains too large for the direct isolation of expressed sequences. We must however remain cautious in accepting these data since apparently significant linkages with both bipolar disorder and schizophrenia have turned out to be falsely positive. 38, 39 On the other hand this is the first time that data suggesting a major gene locus for psychoses have been found in independent datasets, as is the case here.
